Watchmaker Genomics develops high-performance enzymes and library preparation kits for next-generation sequencing (NGS) applications, addressing the limitations of current reagents that hinder accurate genomic analysis. Their products enhance throughput and sensitivity for a range of applications, including single-cell sequencing and CRISPR-based editing, enabling researchers to obtain reliable data from diverse sample types.
Funding
$48.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current enzymes and reagents used in next-generation sequencing (NGS) applications often limit the accuracy and sensitivity of genomic analysis, hindering advancements in omics and molecular biology. These limitations can result in unreliable data, especially when working with challenging samples or applications requiring high sensitivity.
Solution
Watchmaker Genomics develops and manufactures high-performance enzymes and library preparation kits designed to overcome the limitations of existing NGS reagents. By leveraging protein engineering, computational biology, and enzyme manufacturing, Watchmaker Genomics creates precision tools that enhance the throughput, sensitivity, and accuracy of NGS workflows. Their products enable researchers to obtain reliable and clinically relevant data from diverse sample types, including low-input and degraded samples, thereby accelerating discoveries in areas such as inherited disease, somatic oncology, and transcriptomics.
Target Audience
The primary target audience includes researchers and clinical labs performing next-generation sequencing for applications such as inherited disease analysis, somatic oncology research, single-cell sequencing, and whole-genome sequencing.
Features
- DNA library preparation kits with high conversion rates, reduced bias and artifacts, and reproducible results
- RNA library preparation kits with rapid workflows (under 5 hours) and high sensitivity for low-input and FFPE samples
- Equinox library amplification kits delivering excellent fidelity, uniform sequence coverage, and high library complexity
- A range of DNA polymerases (Taq, phi29, T4, DNA Polymerase I, StellarTaq) and reverse transcriptases (StellarScript, StellarScript HT, StellarScript HT+)
- RNase inhibitors for single-cell, single-nuclei, and pathogen detection applications
- Custom solutions for developers of cutting-edge technologies pushing the limits of molecular biology and genomics